Multi-Disciplinary Organization Dedicated to Promoting Advances in
Neuro-Oncology Through Research and Education

REGISTER NOW - SNO Pediatric Research Conference

Join us in the Big Apple, New York City! Read for registration, exhibit/support opportunities, program ...

Read Full Story

Neuro-oncology Certification and Recertification Examination Application Deadline Extended

Deadline March 31, 2017

Read Full Story

Call for Proposals - Neuro-Oncology Courses

Deadline April 30 for courses to be held in developing countries

Read Full Story
View All News

May
04

5th Quadrennial Meeting of the World Federation of Neuro-Oncology Societies (WFNOS)

Read Full Story

May
18

Brain Tumor Berlin 2017

Read Full Story

June
07

5th International CNS Germ Cell Tumor Symposium

Read Full Story

WFNOS Magazine

 

The Society for Neuro-Oncology (SNO)
and the European Association of Neuro-Oncology (EANO)
have the pleasure to announce the publication of the first issue of the
World Federation of Neuro-Oncology Societies (WFNOS) Magazine

This new magazine is a transition from the EANO magazine and pursues the mission
to become a central platform for communication for all those interested in neuro-oncology,
including professionals involved in the diagnosis and care of brain tumor patients across the world.

 

 WFNO_Magazine.png

 

Table of Contents

  • NSCLC Cell Adhesion to and Transmigration through Brain Endothelium in Brain Metastasis
  • Prevention of Brain Metastasis by Inhibition of Angiogenesis?
  • Glioblastoma: Example of Translational Research in Radiotherapy and Radiobiology
  • Development of a Questionnaire to Measure Instrumental Activities of Daily Living (IADL) in Patients with Brain Tumors
  • A pro/con debate on the first-line treatment of patients with high-grade gliomas: An interview with Roger Stupp and Michael Prados
  • Indian Society of Neuro-Oncology: Challenges and Opportunities
  • Nurses Corner
  • Brain Tumor Patient Advocacy—Who Needs It?
  • Targeting IDH1R132H in WHO grade III and IV IDH1R132H-mutated gliomas by a peptide vaccine: a first-in-man phase I safety, tolerability, and immunogenicity multicenter trial (NOA-16)
  • Hotspots in Neuro-Oncology 2016

To view the entire Volume 1 (2016) Issue 1, please click here (pdf)